TD Cowen Keeps Their Buy Rating on Allogene Therapeutics (ALLO)
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) yesterday. The company’s shares ...
Alphabet price target lowered to $210 from $220 at TD Cowen
TD Cowen lowered the firm’s price target on Alphabet (GOOG) to $210 from $220 and keeps a Buy rating on the shares. The firm updated its model ...